K
Kimihiko Abe
Researcher at Tokyo Medical University
Publications - 81
Citations - 2174
Kimihiko Abe is an academic researcher from Tokyo Medical University. The author has contributed to research in topics: Magnetic resonance imaging & Dementia with Lewy bodies. The author has an hindex of 26, co-authored 80 publications receiving 2067 citations.
Papers
More filters
Journal ArticleDOI
Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease.
TL;DR: The results suggest that decreased fiber density, such as the disruption and loss of axonal membranes or myelin, occur early in the temporal stem, probably due to secondary degeneration related to grey matter pathology including the medial temporal lobe.
Journal ArticleDOI
Gd-EOB-DTPA Enhanced MRI for Hepatocellular Carcinoma: Quantitative Evaluation of Tumor Enhancement in Hepatobiliary Phase
TL;DR: HCCs and some of the dysplastic nodules showed hypointensity in the hepatobiliary phase in Gd-EOB-DTPA-enhanced MRI and no specific enhancement was observed, regardless of tumor differentiation.
Journal ArticleDOI
Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer's disease.
Haruo Hanyu,Tetsuichi Asano,Hirofumi Sakurai,Yukari Imon,Toshihiko Iwamoto,Masaru Takasaki,Hiroaki Shindo,Kimihiko Abe +7 more
TL;DR: Structural changes of the corpus callosum in patients with Alzheimer's disease (AD) using sagittal diffusion-weighted and magnetization transfer (MT) imaging and DW and MT imagings probably reflect structural changes in the corpusCallosum including axonal loss and/or demyelination.
Journal Article
MR Analysis of the Substantia Innominata in Normal Aging, Alzheimer Disease, and Other Types of Dementia
TL;DR: MR analysis reveals age-related shrinkage of the substantia innominata, which reflects degeneration in the nucleus basalis of Meynert, is pronounced both in patients with AD and in those with non-AD dementia.
Journal ArticleDOI
Comparative value of brain perfusion SPECT and [123I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer’s disease
Haruo Hanyu,Soichiro Shimizu,Kentaro Hirao,Hidekazu Kanetaka,Toshihiko Iwamoto,Taishiro Chikamori,Yasuhiro Usui,Akira Yamashina,Kiyoshi Koizumi,Kimihiko Abe +9 more
TL;DR: MIBG myocardial scintigraphy may improve the sensitivity in the detection ofDLB and provide a powerful differential diagnostic tool when it is difficult to distinguish cases of DLB from AD using brain perfusion SPECT.